UK's PureTech climbs after successful US FDA meeting

Shares of PureTech Health PRTC.L up 4.1% at 127p

Stock among top gainers on FTSE Small Cap index .FTSC, which is flat

Co announces successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

YTD, including session’s gains, stock down about 15%, while .FTSC is up nearly 8%